Skip to main content
. 2022 Sep 20;9:981001. doi: 10.3389/fmed.2022.981001

Figure 2.

Figure 2

Kaplan-Meier survival curves of hepatocellular carcinoma patients treated with anti- PD-1 were analyzed in those without immune- related adverse events according to BMI levels. The PFS of overweight patients with irAEs was significantly longer than that of non-overweight patients (log-rank test). BMI, body mass index. non-over weight BMI ≤ 24.9, over weight BMI > 24.9.